Acute gain in minimal lumen area following implantation of everolimus-eluting ABSORB biodegradable vascular scaffolds or xience metallic stents: Intravascular ultrasound assessment from the ABSORB II Trial.

ホーム
論文
Acute gain in minimal lumen area following implantation of everolimus-eluting ABSORB biodegradable vascular scaffolds or xience metallic stents: Intravascular ultrasound assessment from the ABSORB II Trial.

Acute gain in minimal lumen area following implantation of everolimus-eluting ABSORB biodegradable vascular scaffolds or xience metallic stents: Intravascular ultrasound assessment from the ABSORB II Trial.

2016.06.27

Impact factor 5 over

雑誌：JACC Cardiovasc Interv. 2016 Jun 27;9(12):1216-27.

著者：Sotomi Y, Ishibashi Y, Suwannasom P, Nakatani S, Cho YK, Grundeken MJ, Zeng Y, Tateishi H, Smits PC, Barragan P, Kornowski R, Gershlick AH, Windecker S, van Geuns RJ, Bartorelli AL, de Winter RJ, Tijssen J, Serruys PW, Onuma Y.